AdvisorShares Psychedelics ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.99
資產淨值: 19.95
成立日期: 15/09/2021
 
分析
市值分佈:
18.47%
大市值
34.61%
中市值
42.93%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 04/04/2026 06:03) 總持有投資項目: 25  
0%
 
100%
     10大 (63.60%)
代號 名稱 佔比% 持有日期
RLMDRelmada Therapeutics10.2631/03/2026
ATAIAtaiBeckley Inc10.0131/03/2026
DFTXDefinium Therapeutics Inc8.6031/03/2026
CMPSCOMPASS Pathways Plc6.8031/03/2026
NBIXNeurocrine Biosciences4.7131/03/2026
GHRSGH Research PLC4.7031/03/2026
HELPCybin Inc4.6831/03/2026
ALKSAlkermes plc4.6531/03/2026
JNJJohnson & Johnson4.6031/03/2026
ANROAlto Neuroscience4.6031/03/2026
DRUGBright Minds Biosciences4.5931/03/2026
ABBVABBVIE4.5131/03/2026
SUPNSupernus Pharmaceuticals4.5031/03/2026
NRXPNRX Pharmaceuticals4.4631/03/2026
STIMNeuronetics4.4631/03/2026
NEUPNeuphoria Therapeutics Inc3.1531/03/2026
QNTMQuantum Biopharma Ltd2.6131/03/2026
KTTAPasithea Therapeutics Corp1.2531/03/2026
SILOSilo Pharma1.1931/03/2026
VTGNVistagen Therapeutics, Inc.0.7931/03/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.